论文部分内容阅读
１４１ 例乙型病毒性肝炎肝硬化食管静脉曲张出血的病人分为两组，治疗结束后两组复查胃镜各为６８ 例，食管静脉曲张结扎（ＥＶＬ）组和食管静脉硬化治疗（ＥＶＳ）组食管静脉曲张消失和基本消失分别为５６ 例（８２．３％ ）、６２ 例（９１．２％ ），两组比较差异无显著性意义（Ｐ＜ ０．０５）。并发早期再发出血两组各为７ 例，ＥＶＬ组死亡３ 例，ＥＶＳ组无死亡。１年内定期胃镜检查，食管静脉曲经复发ＥＶＬ组复查６６ 例，复发２６ 例（３９．４％ ），ＥＶＳ组复查６１例复发１３ 例（２１％ ），差别有显著性意义（Ｐ＜ ０．０５），而且两者静脉曲张复发形式程度有所不同。随访期间复发出血在１２、２４、３８ 个月内ＥＶＬ组分别为７．６％ 、２．１％ 、０％ ；ＥＶＳ组为９．８％ 、４．２％ 、４．４％ ，差异无显著性意义（Ｐ＞ ０．０５）。
One hundred and seventy-one patients with hepatitis B cirrhosis and esophageal variceal bleeding were divided into two groups. After the treatment, 68 cases of esophagogastric varices were enrolled in both groups. The esophageal varices ligation (EVL) and esophageal varices (EVS) The disappearance and disappearance of varicose veins were 56 cases (82.3%) and 62 cases (91.2%), respectively. There was no significant difference between the two groups (P <0.05). Complications of early recurrence of hemorrhage in each of two groups of seven cases, EVL group died in 3 cases, EVS group no death. Sixty-six patients (39.4%) had recurrent esophageal varices in EVL group and 13 (21%) in 61 EVS patients. The difference was significant (P <0. 05), and the degree of varicose veins recurrence between the two forms is different. The recurrence of hemorrhage during follow-up was 7.6%, 2.1% and 0% in EVL group at 12, 24 and 38 months respectively, and 9.8%, 4.2% and 4.4% in EVS group, respectively. Significant significance (P> 0.05).